ACOG committee opinion. Tamoxifen and endometrial cancer. Number 169, February 1996. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.
D001943:Breast Neoplasms / Q000188:drug therapy*; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000517:prevention & control; D004965:Estrogen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008403:Mass Screening; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use
D004965:Estrogen Antagonists; D013629:Tamoxifen